Back
Metalpha Technology Holding Vs. Celldex Therapeutics Industry Stock Comparison
Buy
54
MATH
Metalpha Technology Holding
Last Price:
1.15
Seasonality Move:
17.1%
Sell
37
CLDX
Celldex Therapeutics
Last Price:
32.87
Seasonality Move:
1.08%
Buy
54
Metalpha Technology Holding (MATH)
is a Buy
Is Metalpha Technology Holding a Buy, Sell or Hold?
- The current Metalpha Technology Holding [MATH] share price is $1.18. The Score for MATH is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- MATH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics a Buy, Sell or Hold?
- The current Celldex Therapeutics [CLDX] share price is $36.02. The Score for CLDX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- CLDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MATH Stock Price Chart
What is Metalpha Technology Holding's stock price today?
-
The Metalpha Technology Holding share price today is $1.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MATH is experiencing slight buying pressure.
CLDX Stock Price Chart
What is Celldex Therapeutics's stock price today?
-
The Celldex Therapeutics share price today is $36.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDX is experiencing slight selling pressure.
MATH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 51.48 | Buy |
| Chaikin Money Flow: | 1129 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.07 - 1.21) | Buy |
| Bollinger Bands (100): | (1.16 - 1.44) | Sell |
CLDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 37.46 | Sell |
| Chaikin Money Flow: | -2311480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.03 - 43.15) | Sell |
| Bollinger Bands (100): | (34.54 - 41.04) | Sell |
MATH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.18 | Buy |
| 20-day SMA: | 1.13 | Buy |
| 50-day SMA: | 1.19 | Sell |
| 200-day SMA: | 1.44 | Sell |
| 8-day EMA: | 1.18 | Buy |
| 20-day EMA: | 1.16 | Buy |
| 50-day EMA: | 1.2 | Sell |
| 200-day EMA: | 1.33 | Sell |
CLDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.69 | Sell |
| 20-day SMA: | 41.52 | Sell |
| 50-day SMA: | 38.47 | Sell |
| 200-day SMA: | 38.87 | Sell |
| 8-day EMA: | 40.13 | Sell |
| 20-day EMA: | 40.37 | Sell |
| 50-day EMA: | 39.15 | Sell |
| 200-day EMA: | 37.62 | Sell |
Metalpha Technology Holding Earnings Growth & MATH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Celldex Therapeutics Earnings Growth & CLDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
Metalpha Technology Holding Technical Analysis
| Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Celldex Therapeutics Technical Analysis
| Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||